Lexicon Pharmaceuticals, Inc.
Market Cap
840M
Short interest (May 15)
5.9%
Net Short (Jun 03 ): -0.1%
Borrow Fee
0.40%
↓ 17.1%
Available Shares
3M
↓ 0.8%
Price Chart
Company Overview
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.